Skip to main content
. 2020 Jul 13;12(6):1046–1059. doi: 10.4168/aair.2020.12.6.1046

Table 2. Severe adverse events according to rapid drug desensitization.

Severe adverse events RDD group (n = 104) Control group (n = 271)
Death 1 (1.0) 0 (0.0)
Cardiac disorders 0 (0.0) 1 (0.4)
Gastrointestinal disorders (except nausea) 0 (0.0) 8 (3.0)
Infection and infestations 6 (5.8) 11 (4.1)
Injury, poisoning and procedural complications 0 (0.0) 1 (0.4)
Nausea and nutrition disorders 2 (1.9) 8 (3.0)
General disorders 0 (0.0) 3 (1.1)
Respiratory, thoracic and mediastinal disorders 0 (0.0) 1 (0.4)
Skin and subcutaneous tissue disorders 0 (0.0) 1 (0.4)
Total 8 (7.7) 34 (12.5)

RDD, rapid drug desensitization.